Patent details

Basic Information

Publication number:

EP3694497

PCT Application Number:

EP2018077790

Type:

European Patent Granted for LU

Legal Status:

Unitary Effect Registered

Application number:

EP187887187

PCT Publication Number:

WO2019072996

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING A SILICONE ACRYLIC HYBRID POLYMER

French Title of Invention:

SYSTÈME THÉRAPEUTIQUE TRANSDERMIQUE POUR L'ADMINISTRATION TRANSDERMIQUE DE GUANFACINE COMPRENANT UN POLYMÈRE ACRYLIQUE HYBRIDE DE SILICONE

German Title of Invention:

TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR TRANSDERMALEN VERABREICHUNG VON GUANFACIN MIT EINEM SILIKON-ACRYL-HYBRIDPOLYMER

SPC Number:

Unitary Effect

Unitary Effect Requested:

Yes

Unitary Effect Request Filing Date:

06/07/2023

Link to UPP Register:

European Patent Register

Unitary Effect Request Withdrawal Date:

Unitary Effect Status:

Unitary Effect Registered

Unitary Effect Acceptance Decision Date:

17/07/2023

Unitary Effect Rejection Decision Date:

Unitary Effect Date:

07/06/2023

Unitary Effect Registration Date:

17/07/2023

Unitary Effect Re-establishment of rights Filing Date:

Unitary Effect Re-establishment of rights EPO Decision :

Unitary Effect Re-establishment of rights EPO Decision Date:

Explanatory Text UE:

Safety Net Request Date:

Safety Net Decision Date:

Safety Net Decision Outcome:

SPC Number:

Dates

Filing date:

11/10/2018

Grant date:

07/06/2023

EP Publication Date:

19/08/2020

PCT Publication Date:

18/04/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/06/2023

EP B1 Publication Date:

07/06/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/10/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/09/2023

 

 

Name:

DDP Specialty Electronic Materials US 9, LLC

Address:

974 Center Road, Wilmington, DE 19805, United States (US)

Name:

LTS Lohmann Therapie-Systeme AG

Address:

Lohmannstraße 2, 56626 Andernach, Germany (DE)

History of Owners

From:

31/05/2023

To:

22/09/2023

Name:

Dow Silicones Corporation

Address:

2200 West Salzburg Road, Midland, MI 48686-0994, United States (US)

Name:

LTS Lohmann Therapie-Systeme AG

Address:

Lohmannstraße 2, 56626 Andernach, Germany (DE)

Inventor

1

Name:

EMGENBROICH, Marco

Address:

Germany (DE)

2

Name:

KLUTH, Heike

Address:

Germany (DE)

3

Name:

THOMAS, Xavier

Address:

France (FR)

4

Name:

KLEIN, Elke

Address:

Germany (DE)

5

Name:

PRINZ, Eva-Marie

Address:

Germany (DE)

6

Name:

NARTKER, Linda Sue

Address:

United States (US)

Priority

1

Priority Number:

201762570748 P

Priority Date:

11/10/2017

Priority Country:

United States (US)

2

Priority Number:

17205538

Priority Date:

05/12/2017

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/70; A61P 9/12; A61P 25/00; A61K 31/165;

Publication

European Patent Bulletin

1

Issue number:

202323

Publication date:

07/06/2023

Description:

Grant (B1)

2

Issue number:

202332

Publication date:

09/08/2023

Description:

Unitary Effect Request Receipt

3

Issue number:

202333

Publication date:

16/08/2023

Description:

Unitary Effect Request Acceptance

4

Issue number:

202343

Publication date:

25/10/2023

Description:

Transfer of Rights

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages